Literature DB >> 32986462

Épidémiologie descriptive du risque suicidaire dans le système médical français de médecine générale.

J-L Ducher1, P-M Llorca2, S Callahan3, I de Chazeron2.   

Abstract

OBJECTIVE: Suicide prevention certainly includes a better knowledge of suicide risk in primary care. A number of international publications have shown interest in assessing this risk, but mostly through specific consultant populations: young patients, old patients, anhedonic, depressive, etc. Our study analyses suicide risk prevalence in patients consulting in general medicine for any somatic or psychiatric reason, their pathology or their age.
METHOD: This cross-sectional study was conducted with adult patients (827 subjects included) who were consulting a French generalist doctor panel randomly selected. They filled a validated self-questionnaire (aRSD) assessing their suicide risk in the 15 preceding days and providing professional and personal data.
RESULTS: The totally operable 757 files (483 female; 274 male) show that close to a quarter of consultants (24.3%) presents with a positive suicide risk in the 15 days preceding their consultation and 6.3%, reveal a severe risk (aRSD ≥ 7) with ideas and impulses to commit the act. When the reason to consult is psychiatric, 64.6% of these consultants have aRSD positive. One time out of two, the risk is even severe.
CONCLUSIONS: This data shows how important the suicide risk prevalence is in general medicine. It confirms the main role played by primary care patricians in acting to prevent suicide risk. This data also shows the contribution represented by a self-questionnaire that would rapidly assess the suicide intent while screening, it.

Entities:  

Keywords:  Suicide; médecine générale; risque suicidaire; santé primaire; épidémiologie

Year:  2020        PMID: 32986462      PMCID: PMC8107957          DOI: 10.1177/0706743720961741

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  28 in total

1.  [No! The number of suicides in France is not decreasing].

Authors:  J-L Ducher; P M Llorca
Journal:  Encephale       Date:  2012-05-26       Impact factor: 1.291

2.  Increase in Suicide in the United States, 1999-2014.

Authors:  Sally C Curtin; Margaret Warner; Holly Hedegaard
Journal:  NCHS Data Brief       Date:  2016-04

3.  Assessment of suicidal intention: the Scale for Suicide Ideation.

Authors:  A T Beck; M Kovacs; A Weissman
Journal:  J Consult Clin Psychol       Date:  1979-04

4.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

5.  [Factors associated with suicidal risk among consulting young people in a preventive health center].

Authors:  E Larosa; S M Consoli; T Hubert-Vadenay; H Leclésiau
Journal:  Encephale       Date:  2005 May-Jun       Impact factor: 1.291

6.  Suicide within 12 months of contact with mental health services: national clinical survey.

Authors:  L Appleby; J Shaw; T Amos; R McDonnell; C Harris; K McCann; K Kiernan; S Davies; H Bickley; R Parsons
Journal:  BMJ       Date:  1999-05-08

7.  [Is the suicidal risk assessment scale RSD of predictive value?].

Authors:  J L Ducher; J L Terra
Journal:  Encephale       Date:  2006-10       Impact factor: 1.291

8.  [Concurrent validation of the suicidal risk assessment scale (R.S.D.) with the Beck's suicidal ideation scale].

Authors:  J-L Ducher; J Daléry
Journal:  Encephale       Date:  2004 May-Jun       Impact factor: 1.291

9.  Evaluation of suicidal patients: the SAD PERSONS scale.

Authors:  W M Patterson; H H Dohn; J Bird; G A Patterson
Journal:  Psychosomatics       Date:  1983-04       Impact factor: 2.386

10.  Physicians' characteristics associated with exploring suicide risk among patients with depression: a French panel survey of general practitioners.

Authors:  Aurélie Bocquier; Elodie Pambrun; Hélène Dumesnil; Patrick Villani; Hélène Verdoux; Pierre Verger
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.